Summary A trophoblast cell surface antigen has been characterised by a monoclonal antibody (mAb) 5T4, raised following immunisation with solubilised wheat germ agglutinin binding glycoproteins from human syncytiotrophoblast plasma membrane (StMPM). The expression of the 72 kDa glycoprotein was assessed on cryostat sections of a range of neoplastic and non-neoplastic tissues, using an avidin-biotin immunoperoxidase technique. In products of conception, intense reactions were noted with villous syncytiotrophoblast membrane in normal early and term placenta, with weaker positivity of placental site trophoblast. Most normal or non-neoplastic tissues were negative, including liver, kidney, spleen, small intestine, ovary Specifically, sections were washed in two changes of tris buffered saline (TBS) pH 7.6 and then covered with 10% normal horse serum in TBS for 20 min. After draining, the slides were incubated with neat culture supernatant for 30 min in a moist chamber. Following three washes in TBS (5 min each), biotinylated anti-mouse Ig (Vector Laboratories) diluted 1/250 in TBS containing 10% normal human serum was applied. After 30 min incubation in the moist chamber, the slides were washed three times and incubated with the avidin-biotin peroxidase complexes reagent (Vector Laboratories) for 50 min. After three washes in TBS, peroxidase was visualised using a freshly prepared and filtered solution of diaminobenzidine tetrahydrochloride (DAB-Sigma) in TBS containing 0.03% hydrogen peroxide (6 min). Sections were washed in tap water and counterstained in Coles' haematoxylin, dehydrated, cleared and mounted (Ralmount-R.A. Lamb). The immunohistochemical results were interpreted with reference to a set of controls run in parallel with each test. These included sections treated with DAB only to show endogenous peroxidase, omission of the primary antibody and replacement of the primary antibody with one of the same class but of unrelated specificity. Reactivity of mAb 5T4 with fixed and paraffin wax embedded sections of term placental trophoblast was also assessed by immunoperoxidase. 5T4 mAb reactivity was assessed by P.J.S. and G.M.B. and the intensity of staining was scored on an arbitrary scale ( + to + + + ). Very weak or equivocal reactions were scored + /-.
5T4 (mAb) recognises a trophoblast glycoprotein of 72 kDa which is also expressed by many carcinoma tumour cell lines (Hole & Stern, 1988) . Previous studies have suggested a relatively restricted normal adult tissue distribution. Uisng a semi-quantitative immunodot assay, brain, muscle, kidney, liver, ovary and testes were shown to express at least 1,000-fold less 5T4 antigen than term placenta. Several previously described trophoblast and/or fetal antigens show a similar pattern of expression by transformed cell lines to 5T4 antigenic molecules (Johnson, 1984) . In some cases there is trophoblast antigen expression by tumour cell lines derived from antigen negative tissues. This may reflect the inappropriate expression of a trophoblast molecule, for example hCG is expressed by some tumours of breast, intestinal and ovarian origins (Vaitukakis, 1979) . Alternatively, minor subpopulations of cells within 'negative' normal tissues may express 5T4 antigenic molecules; hence expression by some, but not all, transformed cell lines could simply reflect a clonal expansion of this putative sub-population of 5T4 antigen positive cells. Trophoblast antigen expression may also result from the adaptation of some cell lines to in vitro culture; for example, despite an absence of PLAP expression by amniotic epithelium, the amnion cell line AV-3 has been shown to express the antigen (McLaughlin et al., 1982) . The most interesting possibility is that 5T4 antigen expression by tumour cell lines follows transformation to the neoplastic phenotype. If this is the case, then a variety of neoplastic tumour tissues should be antigen positive. Together with a relatively restricted normal tissue antigen distribution, the 5T4 antibody would be potentially useful in diagnosis, tumour localisation and drug targeting (Baldwin & Byers, 1987) . This study evaluates the distribution of the antigen recognised by mAb 5T4 in normal and neoplastic tissues by immunohistochemistry. Specifically, sections were washed in two changes of tris buffered saline (TBS) pH 7.6 and then covered with 10% normal horse serum in TBS for 20 min. After draining, the slides were incubated with neat culture supernatant for 30 min in a moist chamber. Following three washes in TBS (5 min each), biotinylated anti-mouse Ig (Vector Laboratories) diluted 1/250 in TBS containing 10% normal human serum was applied. After 30 min incubation in the moist chamber, the slides were washed three times and incubated with the avidin-biotin peroxidase complexes reagent (Vector Laboratories) for 50 min. After three washes in TBS, peroxidase was visualised using a freshly prepared and filtered solution of diaminobenzidine tetrahydrochloride (DAB-Sigma) in TBS containing 0.03% hydrogen peroxide (6 min). Sections were washed in tap water and counterstained in Coles' haematoxylin, dehydrated, cleared and mounted (Ralmount-R.A. Lamb). The immunohistochemical results were interpreted with reference to a set of controls run in parallel with each test. These included sections treated with DAB only to show endogenous peroxidase, omission of the primary antibody and replacement of the primary antibody with one of the same class but of unrelated specificity. Reactivity of mAb 5T4 with fixed and paraffin wax embedded sections of term placental trophoblast was also assessed by immunoperoxidase. 5T4 mAb reactivity was assessed by P.J.S. and G.M.B. and the intensity of staining was scored on an arbitrary scale ( + to + + + ). Very weak or equivocal reactions were scored + /-.
Materials and methods

Immunohisitochemistry
Flow cytometric analyses of human bone marrow cells labelled in PBS, 1% BSA 0. 1% azide with 5T4 mAb followed by 1/20 rabbit anti-mouse Ig-FITC (Serotec, Bicester, UK) was performed on a Becton-Dickenson FACS analyser. The purified mAb 5T4 at 10 ig ml-' was tested for interference with the growth of human pluripotential haematopoietic colonies as described by Welte et al. (1985) .
Radioimmunoassay
Syncytiotrophoblast microvillous plasma membranes (StMPM) were prepared as previously described (Hole & Stern, 1988) and were solubilised in 1% deoxycholate (DOC) in tris buffer saline pH 8.0 at a concentration of 3.5 mg ml-'. 5T4 mAb was purified from 1 litre of tissue culture supernatant as follows. The 
Immunohistochemistry
The distribution of positive reactions with mAb 5T4 in normal and non-neoplastic tissues is summarised in Table I . The villous syncytiotrophoblast from first and third trimester placentae (Figure la, b) and ectopic tubal pregnancy showed strong membrane positivity. Placental site trophoblast displayed both membrane and cytoplasmic reactions. Villous cytotrophoblast, the stroma of chorionic villi and fetal blood vessels were negative.
In the non-neoplastic tissues examined, weak or moderate reactions were found in the basal layer of stratified squamous epithelium (cervix, oesophagus and skin), glandular epithelium of endocervix and endometrium, mucosal glands of stomach and large intestine and some excretory ductal epithelium of pancreas. All components of normal brain, liver (Figure lc), small intestine, ovary, testis or lymphoid tissues were unreactive with mAb 5T4. Occasional reactivity with elements in some normal tissues are noted in Table I .
Flow cytometry analysis of bone marrow cell populations indicated no reactive cells and the antibody did not interfere with the development of haemopoietic precursor colonies in culture (data not shown). Table II summarises the distribution of mAb 5T4 labelling in neoplastic tissues. Many malignant epithelial tumours displayed positive reactions: of note, were carcinomas of bladder (4/4), breast (5/5), cervix (5/5), lung (8/8) including four squamous cell carcinomas, stomach (6/7) and pancreas including one of the ampulla of Vater (4/4). Figure 2 illustrates immunohistochemistry of squamous carcinoma of the lung and cervix, invasive ductal adenocarcinoma of the breast and adenocarcinoma of the endometrium. One of three neuroblastomas showed significant 5T4 expression associated with both membrane and cytoplasm as did a single apendyoma: a glioblastoma multiforme was negative. The (Figure 3a, b) . Much of the trophoblast of placental site tumours showed moderate or strong labelling on both cell membranes and within the cytoplasm (Figure 3c) . In examples of fibrosarcoma and leiomyosarcoma most tumour cells were negative, with some focal and weak reactions in a few cells, but a sarcoma from the soft part of the alveolus exhibited generalised cytoplasmic reactivity. Malignant melanomas (five) and malignant lymphomas (three) were negative. The stroma of some tumours showed weak and focal reactions. This was also noted in the endothelium lining some small blood vessels in many tissues and tumours (see fetal colon, Figure Id) .
The cellular location of binding with mAb 5T4 in tumours is either membranous or cytoplasmic or a combination of both. Heavy membrane-bound location is a particular feature of syncytiotrophoblast. Cytoplasmic reactivity was predominant in pancreatic carcinomas. In gastric and breast carcinomas, both types of pattern were present. MAb 5T4 was unreactive with fixed and paraffin wax embedded tissue sections of villous trophoblast of term placentae. Figure 4 illustrates an example of an assay for soluble antigen in human serum. '251-labelled purified 5T4 mAb is bound to microtitre plates with bound solubilised StMPM and competed by the latter or serum. The sensitivity of this assay for 5T4 antigen is 0.1 ng ml-' (see Discussion). No significant 5T4 antigen was detected in serum diluted 1/100 compared with normal goat serum similarly diluted. This assay establishes that the 5T4 antigen in normal serum must be less than 10 ng ml-'. Assays on seven normal nonpregnant sera, five first trimester, eight third trimester and eight post-partum sera gave similar results.
Radioimmunoassay
Discussion
Mab 5T4 gives reactions in trophoblast which are similar to other antitrophoblast antibodies. However, our detailed immunohistochemical and previous biochemical analysis (Hole & Stern, 1988) shows that the antigen recognised is novel and distinct from the Psubunit of HCG or recently reported urinary gonadotrophin peptide (UGP) (Kardana et al., 1988) , PLAP (Johnson, 1984) , trophoblast-leukocyte common antigen (Stern et al., 1986) and those which react with mAb 18A/C4 and 18B/A5 (Loke et al., 1986) . Some of (Epenetos et al., 1984) , were almost all negative using mAb 5T4. The one case that showed some positivity was a seminoma containing syncytiotrophoblast giant cells, admixed with embryonal carcinoma. In contrast to mAbs reactive with the Regan isoenzyme of PLAP (Johnson, 1984) 5T4 mAb was usually negative with bronchiolar epithelium. Unlike both 18A/C4 and 18B/A5 antibodies mAb 5T4 did not react with villous cytotrophoblast (Loke et al., 1986) .
From the immunohistochemical profile, it appears that 5T4 mAb recognises an antigen with a restricted normal tissue distribution, but is reactive with a wide range of tumours. Our preliminary studies indicate that there is probably less than 10 ng ml-' of 5T4 antigen in normal or pregnant human serum. This is based on the fact that antigen was detectable in 1 jug ml-' of StMPM and that 5T4 antigen purified to homogeneity represents at most 0.001% of the protein in N-40-solubilised StMPM. The purification used WGA and 5T4 affinity chromatography with 10,000 enrichment and up to 70% yield (Hole & Stern, 1990) . Thus, the assay could detect at least 0.1 ng of 5T4 ml-'. Since the highest concentration of serum which showed acceptable non-specific inhibition was a 10-2 dilution, the upper limit for antigen is 10 ng ml-'. These results contrast with changes in expression of PLAP detected, during pregnancy with increasing concentrations to a level of pg ml-' at term (Johnson, 1984) and in patients with either ovarian or testicular cancer or trophoblastic disease (Epenetos et al., 1985; McLaughlin et al., 1983) . In spite of the presence of circulatory antigen, some antibodies have been successfully used in radioimaging of tumours (Baldwin & Byen, 1987) . However, other antibodies have shown poor efficacy in uptake in vivo with circulating antigen present (Martin & Halpern, 1986; Pedley et al., 1988) . Therefore, detection of a membrane antigen may offer significant advantages in radioimmunoscintigraphy and therapy. The development of a solid phase capture assay to achieve higher levels of sensitivity comparable with PLAP assays (McLaughlin et al., 1983) (0.07 ng ml-') will be necessary to measure the precise levels of antigen in serum from patients with different malignancies. The antibody is currently being assessed for targeting in selected patients.
